Beta interferon and thyroid;Interferon bêta et thyroïde

Annales d'Endocrinologie

Volumn 67, Issue 1, 2006, Pages 42-44

  Laaribi, O ^a   Marrakchi, A ^a   Msyah, L ^a   Hafidi, A ^a  

^a IBN SINA HOSPITAL   (Morocco)

Author keywords

Beta interferon; Thyroid

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; IMMUNOLOGICAL ADJUVANT; INTERFERON BETA SERINE; INTERFERON BETA-1B;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; LABORATORY TEST; MULTIPLE SCLEROSIS; RELAPSE; REMISSION; SHORT SURVEY; THYROID FUNCTION TEST; THYROIDITIS; THYROTROPIN BLOOD LEVEL; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; REFERENCE VALUE;

ADJUVANTS, IMMUNOLOGIC; ADULT; FEMALE; HUMANS; INTERFERON-BETA; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; REFERENCE VALUES; THYROIDITIS; THYROTROPIN;

EID: 33645991824     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4266(06)72539-2     Document Type: Article

References (14)

1. Durelli L, Fererro B, Oggero A et al. Thyroid function and autoimmunity during interferon beta-1b treatment: a multicenter prospective study. J Clin Endocrinol Metab 2001 ; 86 : 3525-32.
2. Durelli L, Oggero A, Verdun E. Thyroid function and anti-thyroid antibodies in MS patients screened for interferon treatment. A multicenter study. Journal of the Neurological Sciences 2001 ; 193 : 17-22.
3. IFNβ Multiple Sclerosis Study Group. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995 ; 45 : 1277-85.
4. Kreisler A, de Seze J, Stojkovic T et al. Multiple sclerosis, interferon β and clinical thyroid dysfunction. Acta Neurol Scand 2003 ; 107 : 154-7.
5. Kreiss Y, Cohen O, Pras E et al. Subacute thyroiditis in a patient with MS treated with interferon beta 1-a. Neurology 1999 ; 53 : 1606.
6. Monzani F, Caraccio N, Casolaro A et al. Long-term interferon beta-1b therapy for MS: is routine thyroid assessment always useful? Neurology 2000 ; 55 : 549-52.
7. Niederwieser G, Buchinger W, Bonelli RM et al. Prevalence of autoimmune thyroiditis and non-immune thyroid disease in multiple sclerosis. J Neurol 2003 ; 250 : 672-5.
8. Rocco A, Gargano S, Provenzano A. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection. Neuro Endocrinol Lett 2001 ; 22 : 39-44.
9. Rotondi M, Oliviero A, Profice P et al. Occurrence of thyroid autoimmunity and dysfunction throughout a ninemonth follow-up in patients undergoing interferon-beta therapy for multiple sclerosis. J Endocrinol Invest 1998 ; 21 : 748-52.
10. Vial T, Descotes J. Clinical toxicity of the interferons. Drug Saf 1994 ; 10 : 115-50.
11. Vial T, Descotes J. Immune-mediated side-effects of cytokines in humans. Toxicology 1995 ; 105 : 31-57.
12. Walther EU, Hohlfeld R. Multiple sclerosis: side effects of interferon beta therapy and their management. Neurology 1999 ; 53 : 1622-7.
13. Wei T, Lightman S. The neuroendocrine axis in patients with multiple sclerosis. Brain 1997 ; 120 : 1067-76.
14. Yoshikawa M, Fukui H, Tsujii T. Immunological adverse effects of interferon treatment. Clin immunother 1995 ; 4 : 361-75.